Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-10-21

FDA Approved: ALLERGY AND CONGESTION RELIEF — Supplemental Application (L. Perrigo Company)

View source ↗

Summary

The FDA approved a supplemental application for an allergy and congestion relief product containing loratadine and pseudoephedrine sulfate by L. Perrigo Company…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALLERGY AND CONGESTION RELIEF (Loratadine; Pseudoephedrine sulfate)

Snippet

SUPPL AP for ALLERGY AND CONGESTION RELIEF (LORATADINE, PSEUDOEPHEDRINE SULFATE)